Antonio Simone Laganà (5175026)

No ORCID on file · 7 papers in corpus · active 2021-2025

Study types

  • dataset 7

Condition tags

  • adenomyosis 6
  • endometriosis 1
dataset 2025
·doi:10.3389/fendo.2025.1571727.s005

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s006

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s001

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s002

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s003

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s004

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2021
·doi:10.3389/fendo.2021.760616.s001

BackgroundSingle nucleotide variants (SNVs) FSHB:c.-211G>T, FSHR:c.919G>A, and FSHR:c.2039G>A were reported to be associated with the variability in FSH and LH levels, and in vitro fertilization (IVF) outcomes. In this study, we aimed to ev…